Article
Clusterin is not essential for androgen-regulated involution and regeneration of the normal mouse prostate.
The Prostate - 15 Sept 2006
Fink Dieter, Fazli Ladan, Aronow Bruce, Gleave Martin E, Ong Christopher J
Abstract excerpt
BACKGROUND: Inhibition of clusterin expression has been shown to enhance the sensitivity of prostate cancer cells to chemo and hormone therapy. Clusterin antisense oligonucleotides (ASOs) are currently in phase II human clinical trials for treatment of hormone refractory prostate cancer. However, the role of clusterin in androgen-regulated involution and regeneration of the normal prostate gland has not been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
